Debiopharm’s Pre — Clinical Proof — Of — Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance
For best results when printing this announcement, please click on link below: Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance Despite the remarkable progress made by ADCs, many cancer patients continue to face disease progressio